The latest closing stock price for Aclaris Therapeutics as of November 08, 2024 is 2.64.
An investor who bought $1,000 worth of Aclaris Therapeutics stock at the IPO in 2015 would have $-761 today, roughly -1 times their original investment - a -14.71% compound annual growth rate over 9 years.
The all-time high Aclaris Therapeutics stock closing price was 32.99 on April 17, 2017.
The Aclaris Therapeutics 52-week high stock price is 2.67, which is 1.1% above the current share price.
The Aclaris Therapeutics 52-week low stock price is 0.59, which is 77.7% below the current share price.
The average Aclaris Therapeutics stock price for the last 52 weeks is 1.20.
An investor who bought $1,000 worth of Aclaris Therapeutics stock at the IPO in 2015 would have $-761 today, roughly -1 times their original investment - a -14.71% compound annual growth rate over 9 years.
The all-time high Aclaris Therapeutics stock closing price was 32.99 on April 17, 2017.
The Aclaris Therapeutics 52-week high stock price is 2.67, which is 1.1% above the current share price.
The Aclaris Therapeutics 52-week low stock price is 0.59, which is 77.7% below the current share price.
The average Aclaris Therapeutics stock price for the last 52 weeks is 1.20.